Access in all areas? A round up of developments in market access and health technology assessment: part 8
Journal of Comparative Effectiveness Research · 2025
DOI: 10.57264/cer-2025-0091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Sreeram V Ramagopalan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Health Services Accessibility. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In this update, we discuss the pricing paradox of combination therapies in health technology assessment; examine the Inflation Reduction Act’s impact on pharmaceutical innovation and analyze the revised Dutch economic evaluation guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK.
- ProductLife Group, 10 avenue de l'arche, 92400 Courbevoie, France.
Zitieren
APA
Ramagopalan, S. V., & Pannelay, A. J. (2025). Access in all areas? A round up of developments in market access and health technology assessment: part 8. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2025-0091
Vancouver
Ramagopalan SV, Pannelay AJ. Access in all areas? A round up of developments in market access and health technology assessment: part 8. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2025-0091
BibTeX
@article{Ramagopalan2025,
author = {Ramagopalan, Sreeram V and Pannelay, Annie Jullien},
title = {Access in all areas? A round up of developments in market access and health technology assessment: part 8},
journal = {Journal of Comparative Effectiveness Research},
year = {2025},
doi = {10.57264/cer-2025-0091}
}
EUVIMED